GENE ONLINE|News &
Opinion
Blog

Tulip Chakraborty

WRITTEN BY Tulip Chakraborty

Looking to Overcome Limitations in Gene Therapy Space, PBM Capital Backed Startup Launches with $20 M in Series A
2021-03-02
Roivant Inks $450 Million Worth Drug Discovery Deal with Silicon Therapeutics
2021-02-28
Orna Therapeutics Brings to Market New Therapy to Treat Cancer and Other Diseases
2021-02-26
Libtayo’s Second Approval in One Month Sets Up Lung Cancer Duel with Merck’s Keytruda
2021-02-24
Dermavant Sciences’ Psoriasis Drug Promises in Phase 3 Trials
2021-02-20
BIOCEO21 Highlights: Novel CRISPR Delivery Method Puts the Spotlight on this Early Stage Biotech
2021-02-18
Pacific Biosciences Secures 900 Million Investment to Advance Gene Sequencing
2021-02-13
COVID-19: FDA Grants Emergency Use Authorization for Eli Lilly’s Antibody Combo Therapy
2021-02-10
Biogen Strengthens its Grip on the Multiple Sclerosis Market with Another FDA Approval
2021-02-02
Regeneron Looks to Achieve “Passive Vaccination” with COVID-19 Antibody Cocktail
2021-01-27
Merck Withdraws from COVID-19 Vaccine Race Due to Sub-par Response
2021-01-25
Lilly’s Antibody Treatment Prevents COVID-19 Spread at Nursing Home
2021-01-23
Thermo Fisher Expands Portfolio by Acquiring COVID-19 Diagnostic Company
2021-01-20
Johnson & Johnson’s Single Dose COVID-19 Vaccine is Safe and Promising
2021-01-17
Philadelphia Based Biopharma Raises $88 Million in Series A Financing
2021-01-07
1 2 3 4 8
Scroll to Top